← Leaderboards
Sangeeta Tiwari
University Of Texas El Paso
$1,510,000
Attributed
$1,510,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $377.5K · FY2021–24$500K$375K$250K$125K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$1,510,000 · 1
By mechanism
SC1$1,510,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas El Paso
Same institution · by research overlap
- Hugues Ouellet$1,403,900
- Chu-Young Kim$2,099,855
Others in their field
Other Emerging Leaders on “Enzymes”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Jacob Ruff · Cornell University$22,500,000
- Elke Arenholz · Cornell University$14,750,000
- Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai$14,335,772
- Amitinder Kaur · Tulane University Of Louisiana$12,771,713
Research focus
EnzymesAnabolismBactericideArginineBindingBypassCellsCessation Of LifeCharacteristicsChemotherapyCombined Modality TherapyCross ReactivityCysteineDrug DesignDrug DevelopmentDrug DiscoveryDrug ResistanceDrug Resistance In TuberculosisDrug ScreeningDrug-SensitiveDrug TargetingEnzyme BiosynthesisEnzyme PathwayExtensive Drug Resistance
Grant awards (4)
Development of Drugs to Target Arginine Biosythesis in Mycobacterium tuberculosis$377,500
SC1 · FY2024 · GM · contact PI
Development of Drugs to Target Arginine Biosythesis in Mycobacterium tuberculosis$377,500
SC1 · FY2023 · GM · contact PI
Development of Drugs to Target Arginine Biosythesis in Mycobacterium tuberculosis$377,500
SC1 · FY2022 · GM · contact PI
Development of Drugs to Target Arginine Biosythesis in Mycobacterium tuberculosis$377,500
SC1 · FY2021 · GM · contact PI